Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Process Chemistry

Debut Bio gets UC Irvine enzyme technology

by Melody M. Bomgardner
September 27, 2019 | A version of this story appeared in Volume 97, Issue 38

 

This photo shows the founders of the process chemistry start-up Debut Biotechnology.
Credit: Debut Biotechnology
Founders of San Diego start-up Debut Biotechnology

San Diego–based Debut Biotechnology has secured exclusive licenses to two inventions from the University of California, Irvine, that the company says enable continuous manufacturing of drugs, alcoholic beverages, and cannabinoids. According to Debut, the technology is based on enzyme cartridges and enables the synthesis of high-value products to move from batch to continuous processes. The shift can cut the cost and time of production and save space, water, and energy, the firm says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.